Grenoble, France-based CYTOO, a a provider of innovative enabling technologies for high content cell analysis, has teamed up with Cenix BioScience, a developer of industrial high-content screening applications of RNAi. CYTOO in November closed of a series C funding round of $10 million. New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors [...]

General Fusion is having a happy Cinco de Mayo. The utility-scale fusion power company reeled in $19.5 million in a Series B round that included investors Cenovus Energy, through its Environmental Opportunity Fund, Bezos Expeditions, the personal investment company of Jeff Bezos, Chrysalix Energy Venture Capital, GrowthWorks, Braemar Energy Ventures, Entrepreneurs Fund, Business Development Bank of Canada (BDC), and SET Venture Partners.

Swiss medical device start-up NovaShunt AG has raised roughly $25 million in Series B financing. BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund co-led the round, which included participation from existing shareholders NeoMed and VI Partners. NovaShunt is developing an implantable pump system that continually removes excess abdominal fluid in patients suffering from liver cirrhosis, certain cancers and congestive heart failure.